Moderna Is Trying to Create an Infinite Money Source by Developing “Vaccines” for Diseases Caused by Its Previous “Vaccines”
Subscribe for free to the America First Report newsletter. (The Defender)—During its Vaccines Day Event for investors on March 28, Moderna announced progress on multiple mRNA-based vaccines and therapeutic candidates in its “pipeline.” Three vaccines targeting Epstein-Barr virus (EBV), …
Read More